Patents by Inventor Larry C. Blaszczak
Larry C. Blaszczak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20030236243Abstract: 6(7)-&bgr;-substituted &bgr;-lactam compounds as inhibitors of &bgr;-lactamase activity.Type: ApplicationFiled: May 14, 2003Publication date: December 25, 2003Inventors: Brian K. Shoichet, Larry C. Blaszczak
-
Patent number: 5453502Abstract: The invention provides 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes therefor. These compounds are valuable intermediates useful in the preparation of 1-carba(dethia)cephalosporin antibiotics.Type: GrantFiled: March 16, 1994Date of Patent: September 26, 1995Assignee: Eli Lilly and CompanyInventors: James A. Aikins, Larry C. Blaszczak, Kevin P. Lund, John R. Rizzo
-
Patent number: 5393882Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: February 24, 1993Date of Patent: February 28, 1995Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 5239068Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: April 20, 1992Date of Patent: August 24, 1993Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 5142039Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: September 26, 1990Date of Patent: August 25, 1992Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 5037975Abstract: The invention provides a free radical process for preparing 1-carba(1-dethia)cephalosporin antibiotics with 2-substituted methylcephalosporin 1,1-dioxides wherein the substituent on the 2-methylene group is a free radical precursor group such as a phenyl or alkylseleno group. The latter dioxides are treated with a free radical initiator, e.g., a trialkyltin hydride or actinic radiation at 40.degree. C. to 150.degree. C. to provide the 1-carba-3-cephem and 1-carba-2-cephem products. The invention also provides free radical compounds formed as intermediates in the process.Type: GrantFiled: March 28, 1990Date of Patent: August 6, 1991Assignee: Eli Lilly and CompanyInventor: Larry C. Blaszczak
-
Patent number: 4983732Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with allyloxycarbonyl, t-butoxycarbonyl, naphthyloxycarbonyl, trichloroethyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzhydryloxycarbonyl, p-methoxybenzyloxycarbonyl, or o-nitrobenzyloxycarbonyl.Type: GrantFiled: September 21, 1989Date of Patent: January 8, 1991Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 4939249Abstract: The invention provides a free radical process for preparing 1-carba(1-dethia)cephalosporin antibiotics represented by the formula ##STR1## wherein R is amino or protected amino, R.sub.1 is H or alkoxy, R.sub.3 is H or alkyl, Z is ##STR2## where R.sub.2 is, e.g., H, halogen, or alkyl, or --CH.sub.2 R.sub.2 ' where R.sub.2 ' is, e.g., hydroxy, methoxy, or heterocyclicthio group, and A is a carboxy-protecting group which comprises heating a 2-substituted-methylcephalosporin 1,1-dioxide of the formula ##STR3## wherein R, R.sub.1, R.sub.3, and A are the same as in the formula above and Y is a free radical precursor group, e.g., C.sub.1 -C.sub.6 --Se--, C.sub.1 -C.sub.6 --S--, or phenyl--Se--; with a free radical initiator, e.g., a trialkyltin hydride, radiation, or a cobalt I salophen. Also provided are free radical compounds formed as intermediates in the process.Type: GrantFiled: September 16, 1988Date of Patent: July 3, 1990Assignee: Eli Lilly and CompanyInventor: Larry C. Blaszczak
-
Patent number: 4918185Abstract: This invention relates to certain 3-acylamino-4-(2'-substituted or unsubstituted allyl)-azetidinone products of the formula ##STR1## wherein R.sub.12 is an acyl group;R.sub.13 is hydrogen or methoxy;R.sub.14 is hydrogen, C.sub.1 to C.sub.6 alkyl or cycloalkyl, phenyl, phenyl-C.sub.1 to C.sub.4 alkyl or (protected carboxy)-methyl; andR.sub.15 is hydrogen or an amino protecting group.Type: GrantFiled: May 19, 1988Date of Patent: April 17, 1990Assignee: Eli Lilly and CompanyInventor: Larry C. Blaszczak
-
Patent number: 4771135Abstract: The invention encompasses a process for stereoselective carbon-carbon bond formation at C-4 position of a 3-(acylamino)azetidinone. The process is carried out under free radical conditions using a (2-substituted or unsubstituted allyl)tin reagent. Also encompassed by the invention are certain 4-(substituted selenyl)azetidinone starting materials and the corresponding 4-(2'-substituted or unsubstituted allyl)-azetidinone products.Type: GrantFiled: September 22, 1987Date of Patent: September 13, 1988Assignee: Eli Lilly and CompanyInventor: Larry C. Blaszczak
-
Patent number: 4492694Abstract: 7-(3-Indolyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.Type: GrantFiled: April 12, 1983Date of Patent: January 8, 1985Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, Jan R. Turner
-
Patent number: 4492693Abstract: 7-(3-Benzothienyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.Type: GrantFiled: April 12, 1983Date of Patent: January 8, 1985Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, Stjepan Kukolja, Jan R. Turner
-
Patent number: 4490370Abstract: Naphthylglycyl and tetrahydronaphthylglycyl cephalosporins are potent antibacterial agents and are particularly useful as oral treatments for upper respiratory infections.Type: GrantFiled: April 12, 1983Date of Patent: December 25, 1984Assignee: Eli Lilly and CompanyInventors: Robin D. G. Cooper, Larry C. Blaszczak, Jan R. Turner
-
Patent number: 4320055Abstract: 6.beta.-acylaminopenicillin-1.beta.-sulfoxides are epimerized to 6.alpha.-acylaminopenicillin-1.beta.-sulfoxides using triethylamine and chlorotrimethylsilane. The 6.alpha.-acylaminopenicillin-1.beta.-sulfoxides produced in this process are useful intermediates in the synthesis of 7.beta.-acylamino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam acids, a class of 1-oxa .beta.-lactam antibiotics.Type: GrantFiled: April 7, 1980Date of Patent: March 16, 1982Assignee: Eli Lilly and CompanyInventor: Larry C. Blaszczak
-
Patent number: 4271305Abstract: Novel halogenating compounds, derived from triaryl phosphites and chlorine or bromine are employed to convert 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives. The product 3-halo-3-cephems are antibiotic compounds or intermediates thereto.Type: GrantFiled: December 14, 1979Date of Patent: June 2, 1981Assignee: Eli Lilly and CompanyInventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
-
Patent number: 4230644Abstract: Novel halogenating agents are derived from triaryl phosphites and chlorine or bromine. They are useful in converting 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives.Type: GrantFiled: February 1, 1979Date of Patent: October 28, 1980Assignee: Eli Lilly and CompanyInventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
-
Patent number: 4226986Abstract: Novel halogenating compounds, derived from triaryl phosphites and chlorine or bromine are employed to convert 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives. The product 3-halo-3-cephems are antibiotic compounds or intermediates thereto.Type: GrantFiled: February 1, 1979Date of Patent: October 7, 1980Assignee: Eli Lilly and CompanyInventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
-
Patent number: 4211702Abstract: Penicillin and cephalosporin imino halides are prepared by reacting of 6-acylaminopenicillins or 7-acylamino cephalosporins with a novel chlorinating compound derived from a triaryl phosphite and chlorine or bromine. The imino halide products are intermediates in the preparation of antibiotic compounds.Type: GrantFiled: February 1, 1979Date of Patent: July 8, 1980Assignee: Eli Lilly and CompanyInventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher